Vivelle-dot and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Vivelle-dot (estradiol), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Provera, and have Endometrial cancer.

The phase IV clinical study analyzes which people have Weight loss when taking Vivelle-dot. It is created by eHealthMe based on reports of 3,271 people who have side effects when taking Vivelle-dot from the FDA, and is updated regularly.

What is Vivelle-dot?

Vivelle-dot has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 3,545 Vivelle-dot users. Check the latest studies of Vivelle-dot.

What is Weight loss?

Weight loss is found to be associated with 1,449 drugs and 2,293 conditions by eHealthMe. Check the latest studies of Weight loss.

On Jul, 19, 2026

3,271 people reported to have side effects when taking Vivelle-dot.
Among them, 15 people (0.46%) have Weight loss.

Among these 15 people:

How long have people been on Vivelle-dot when they have Weight loss? *

What is the gender of people who have Weight loss when taking Vivelle-dot? *

female: 100 %
male: 0.0 %

What is the age of people who have Weight loss when taking Vivelle-dot? *

What are other drugs people take besides Vivelle-dot? *

What are other side effects people have besides Weight loss? *

Dyspnea (difficult or laboured breathing): 9 people, 60.00%
Chest Pain: 8 people, 53.33%
High Blood Cholesterol: 8 people, 53.33%
Cardiac Failure Congestive: 7 people, 46.67%
High Blood Pressure: 7 people, 46.67%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 6 people, 40.00%
Diabetes: 6 people, 40.00%
Electrocardiogram Abnormal: 6 people, 40.00%
Enlarged Heart: 6 people, 40.00%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 6 people, 40.00%

What are the existing conditions these people have? *

Endometrial Cancer: 3 people, 20.00%
Thyroid Diseases: 2 people, 13.33%
High Blood Cholesterol: 2 people, 13.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 13.33%
Blood Growth Hormone Decreased: 2 people, 13.33%
Depression: 2 people, 13.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 13.33%
Diabetes: 2 people, 13.33%
Hot Flush (sudden feelings of heat): 2 people, 13.33%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vivelle-dot and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vivelle-dot:

Vivelle-dot (3,545 reports)

Weight loss treatments and more:

Weight loss (62,430 reports)

Browse all side effects of Vivelle-dot:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Weight loss (1,449 drugs)

Browse all the conditions that are associated with Weight loss:

Weight loss (2,293 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on estradiol (the active ingredients of Vivelle-dot) and Vivelle-dot (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.